JAGUAR HEALTH, INC. Current Assets
JAGUAR HEALTH, INC. (JAGX) had Current Assets of $17.53 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-19
- 2026-06-30: Assets, Current $17.53M.
- 2026-03-31: Assets, Current $20.21M.
- 2025-12-31: Assets, Current $20.34M.
- 2025-09-30: Assets, Current $29.40M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $17.53M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $20.21M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $20.34M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $29.40M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $27.90M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $30.44M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $32.20M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $36.64M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $40.11M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $33.71M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $27.96M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $22.06M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $28.23M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $32.36M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $22.32M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $25.21M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $23.36M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $28.47M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $28.43M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $24.00M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $44.29M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $44.10M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $17.79M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $10.72M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $11.61M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $6.84M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $9.52M 10-K · filed 2021-03-31 | $9.52M 10-K · filed 2020-04-03 |
| 2019-09-30 | $7.55M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $7.35M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $7.32M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $8.15M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $7.50M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $6.88M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $10.87M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.80M 10-K · filed 2019-04-10 | |
| 2017-09-30 | $4.24M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $3.96M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.58M 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | $2.56M 10-K · filed 2018-04-09 | |
| 2016-09-30 | $4.08M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.02M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $8.12M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $8.45M 10-K · filed 2017-02-15 | |
| 2015-09-30 | $11.10M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $12.87M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $3.98M 10-Q · filed 2015-06-26 | |
| 2014-12-31 | $3.55M 10-K · filed 2016-03-29 | $3.63M 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |